Date: Aug. 30, 2012
FOR IMMEDIATE RELEASE
IOM and FDA Select Inaugural Tobacco Regulatory Science Fellows
WASHINGTON — The Institute of Medicine and the Food and Drug Administration's Center for Tobacco Products (CTP) have named the first FDA Tobacco Regulatory Science Fellows. The 2012-2013 class is:
- Atanaska Dineva, communications associate, Institute for Global Tobacco Control, Johns Hopkins Bloomberg School of Public Health, Baltimore
- Candice Jongsma, research scientist, ConocoPhillips, Bartlesville, Okla.
- Elizabeth Laposata, research analyst, Center for Tobacco Control Research and Education, University of California, San Francisco
Beginning in September, the three fellows will spend a year in Rockville, Md., where they will actively participate in the development of science-based public health strategies and lead specific projects related to tobacco product regulation. They will also meet with policy leaders and engage in leadership development programs. Each of the fellows will be assigned to one of three offices within CTP for the full year: the Office of Health Communication and Education, Office of Policy, and Office of Science.
"We are pleased to launch the inaugural class of FDA Tobacco Regulatory Science Fellows in this pioneering partnership between the FDA Center for Tobacco Products and the Institute of Medicine," said IOM President Harvey V. Fineberg. "These fellows have an exciting year ahead of them."
"I am delighted that three extraordinary professionals will be bringing their talent and expertise to our work to protect the public health by regulating the manufacture, distribution, and marketing of tobacco products," said CTP Director Lawrence Deyton. "These fellows also will be leaders in the emerging field of regulatory science, especially as it relates to tobacco."
The fellows were chosen in a national competition among highly accomplished professionals in various fields. During their fellowship assignments, they will participate in structured orientation and professional development activities, including opportunities to meet with leaders from FDA, CTP, and the U.S. Department of Health and Human Services; attend congressional hearings; and develop a set of core competencies. In addition, efforts will be made to identify ways for the fellows to participate in D.C.-based activities and gatherings sponsored by other fellowship programs, including Robert Wood Johnson Foundation Health Policy Fellows, American Association for the Advancement of Science Science and Technology Policy Fellows, White House Fellows, and others. The fellows' experience will enrich their understanding about tobacco products and their health consequences as well as afford opportunities to learn about the processes of one of the world's pre-eminent public health regulatory agencies.
Launched in 2012, the FDA Tobacco Regulatory Science Fellowship Program aims to provide an opportunity for mid-career professionals to gain experience and expertise to further define and develop the field of regulatory science as it relates to tobacco products and FDA's new authorities under the Family Smoking Prevention and Tobacco Control Act. Additional information can be found at http://www.iom.edu/Activities/Education/FDAFellowship.aspx.
Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides objective, evidence-based advice to policymakers, health professionals, the private sector, and the public. The Institute of Medicine, National Academy of Sciences, National Academy of Engineering, and National Research Council together make up the independent, nonprofit National Academies. For more information, visit http://national-academies.org or http://iom.edu.
Contact:
Christine Stencel, Senior Media Relations Officer
Office of News and Public Information
202-334-2138; e-mail news@nas.edu
|
